|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 947011
<NAME> Royce Biomedical, Inc.
<MULTIPLIER> 1
<CURRENCY> U.S
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-START> JUL-1-1999
<PERIOD-END> MAR-31-2000
<EXCHANGE-RATE> 1
<CASH> 118,800
<SECURITIES> 0
<RECEIVABLES> 52,600
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 171,900
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 171,900
<CURRENT-LIABILITIES> 118,600
<BONDS> 0
0
0
<COMMON> 14,300
<OTHER-SE> 1,500
<TOTAL-LIABILITY-AND-EQUITY> 171,900
<SALES> 52,000
<TOTAL-REVENUES> 52,000
<CGS> 19,900
<TOTAL-COSTS> 149,900
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (117,800)
<INCOME-TAX> 0
<INCOME-CONTINUING> (117,800)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (117,800)
<EPS-BASIC> (0.04)
<EPS-DILUTED> (0.04)
</TABLE>
|
|